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Abstract
Introduction Mortality from ruptured abdominal aortic
aneurysms (RAAA) remains high. Severe systemic inflammation,
leading to multi-organ failure, often occurs in these patients. In
this study we describe the level of HLA-DR expression in a
consecutive group of patients following surgery for RAAA and
compare results between survivors and non-survivors. A similar
comparison is made for IL-6 and IL-10 levels and Sequential
Organ Failure Assessment (SOFA) scores.
Methods This is a prospective observational study. Patients
with RAAA were prospectively analysed. Blood samples were
collected on days 1, 3, 5, 7, 10 and 14. The fraction of CD-14
positive monocytes expressing HLA-DR was measured by flow-
cytometry. IL-6 and IL-10 levels were measured by ELISA.
Results The study included 30 patients with a median age of 70
years, of which 27 (90%) were men. Six patients died from
multiple organ failure, all other patients survived. The SOFA
scores were significantly higher in non-survivors on days 1
through 14. HLA-DR expression on monocytes was significantly
lower on days 3, 5, 7, 10 and 14 in non-survivors. IL-6 and IL-10
levels were significantly higher in non-survivors on day 1 and
days 1 and 3, respectively.
Conclusion HLA-DR expression on monocytes was decreased,
especially in non-survivors. All patients with RAAA displayed a
severe inflammatory and anti-inflammatory response with an
increased production of IL-6 and IL-10. Poor outcome is
associated with high levels of IL-6 and IL-10 and a high SOFA
score in the first three days after surgery, while low levels of
HLA-DR expression are observed from day three after RAAA
repair.
Introduction
Mortality in patients following repair of a ruptured abdominal
aortic aneurysm (RAAA) remains high (30% to 70%), despite
important advances in emergency medicine, anaesthesiology,
surgery and intensive care [1-5]. The postoperative course of
patients after RAAA repair is almost always characterized by
systemic inflammation, sometimes leading to multiple-organ
failure, a prolonged intensive care unit (ICU) stay and a high
mortality [6-8]. Down-regulation of HLA-DR expression on
monocytes has been reported in different groups of surgical
patients and has been associated with septic complications
and increased mortality [9-13]. We studied the expression of
HLA-DR on monocytes in patients following surgery for RAAA,
taking into account levels of IL-6 and IL-10 and Sequential
Organ Failure Assessment (SOFA) scores. The primary aim of
this study was to describe the level of HLA-DR expression in
APACHE = Acute Physiology and Chronic Health Evaluation; CI = confidence interval; ELISA = enzyme-linked immunosorbent assay; ICU = intensive 
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these patients and to establish, if possible, whether low HLA-
DR expression was associated with increased mortality as a
result of secondary infections.
Materials and methods
Patients and design of the study
Patients with RAAA who survived surgery were prospectively
analysed and included in the study. Patients who underwent
endovascular treatment were excluded. Cases were only clas-
sified as RAAA when an aortic aneurysm and retroperitoneal
or intraperitoneal blood were present. The study was
approved by our Medical Ethics Committee. Written informed
consent was obtained from a family member.
For each patient, one healthy employee of the laboratory
served as normal control.
On days 1, 3, 5, 7, 10 and 14, 10 ml of EDTA blood was with-
drawn from the patient and HLA-DR expression on monocytes
was analysed immediately. For IL-6 and IL-10 measurements
blood was kept on ice, centrifuged at 1,655 g at 4°C for 10
minutes and stored at -80°C until analysis.
Acute Physiology and Chronic Health Evaluation (APACHE)-II
scores were calculated on ICU admission [14]. The SOFA
score was measured daily after surgery [15]. ICU-acquired
infections were defined according to the criteria issued by the
Centres for Disease Control and Prevention. All infections
were recorded prospectively. Sepsis was defined according
to Bone and colleagues [16].
Laboratory analysis
C-reactive protein (normal value <5 mg/dl) and white blood
cell count (normal value 4 to 10 × 109/l) were measured every
day.
IL-6 and IL-10 were measured by ELISA in 26 patients (21 sur-
vivors and five non-survivors), using a monoclonal antibody
against human IL-6 (Sanquin, Amsterdam, the Netherlands) or
IL-10 (BD Pharmingen, Alphen a/d Rijn, the Netherlands).
The percentage of CD-14 positive monocytes expressing
HLA-DR was measured by flow-cytometry. Monoclonal anti-
bodies against CD-14 antigen (anti-CD-14-PE, Immuno Qual-
ity Products, Groningen, the Netherlands) were used to set a
gate for monocytes. The percentage of HLA-DR on monocytes
was determined using anti-HLA-DR fluorescein isothiocyante
(Becton Dickinson Immunocytometry Systems, San Jose, CA,
USA), with an IgG2a isotype control (IgG2a FITC, Immuno
Quality Products). A live gate was set using forward and side-
ward scatter characteristics. A monocyte gate was set by the
CD-14+ group. Data were analysed using Cell Quest software
(Becton-Dickinson).
Statistics
Data are given as median with interquartile range. Differences
between categorical variables were tested with Chi-square
analysis. The Mann-Whitney U or Kruskal-Wallis test was per-
formed to calculate differences in continuous variables. For
detection of correlation we used Spearman's rank correlation
test. The rank correlation coefficients were averaged after z-
transformation. P values < 0.05 were regarded as statistically
significant.
Results
Patients
During the course of the study 46 patients with RAAA were
admitted to our Hospital. All patients were operated upon. Six-
teen patients were not included in this study: six were
endovascular treated, five died during surgery, four patients
were not included because of absence of one of the primary
investigators (JWH or APvdB), and for one patient no informed
consent was obtained.
Of the remaining 30 patients, the median age was 70 (64 to
75) years and 27 patients (90%) were men. Six patients died
and 24 survived until hospital discharge. Clinical characteris-
tics of survivors and non-survivors are shown in Table 1. The
non-survivors were significantly older, had a higher APACHE-
II score and more sigmoid necrosis was observed. Blood-loss,
lowest systolic blood pressure and suprarenal clamping did
not significantly differ between survivors and non-survivors.
Table 2 displays the intra- and postoperative complications of
the non-survivors. The six non-survivors died on days 2, 3, 4,
12, 21 and 30 after RAAA repair. In three of these patients the
sigmoid colon had to be resected because of ischemic necro-
sis. Two patients had a culture proven infection. All patients
died from multiple-organ failure.
The SOFA score did not differ significantly between survivors
and non-survivors upon arrival in the ICU, but was significantly
higher on days one through 14 in the non-survivors (Figure 1).
C-reactive protein and white blood cell count
The median C-reactive protein level increased postoperatively.
In non-survivors and survivors C-reactive protein (mg/dl) was
84 versus 31 on day 1, 283 versus 190 on day 3, 212 versus
157 on day 5 and 167 versus 159 on day 7. The median white
blood cell count (× 109/l) was 9.6 versus 10.0 on day 1, 7.8
versus 9.5 on day 3, 7.9 versus 9.4 on day 5 and 12.6 and
10.0 on day 7 in non-survivors and survivors, respectively. All
differences were non-significant.
Cytokine production
IL-6 and IL-10 were elevated in all RAAA patients post-surgery
(Figures 2 and 3). Median IL-6 was significantly higher in non-
survivors versus survivors on day 1; median (interquartile
range) 543 pg/ml (90 to 701) versus 122 pg/ml (39 to 137),Available online http://ccforum.com/content/10/4/R119
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p = 0.03. IL-10 was significantly higher on days 1 and 3 post-
surgery in the non-survivors (p = 0.03 for both days).
HLA-DR expression on monocytes
On day one after surgery HLA-DR expression on monocytes
was comparable in survivors and non-survivors, and signifi-
cantly lower than the 76% to 96% observed in healthy con-
trols. In survivors, HLA-DR expression rose to normal levels,
whereas it decreased further and remained low in non-surviv-
ing patients. Percentages of monocytes expressing HLA-DR
were significantly lower on days 3, 5, 7, 10 and 14 in the
patients who died (Figure 4) compared to survivors. No signif-
icant differences were found between HLA-DR expression in
the patients who developed infections (two non-survivors and
seven survivors) and those who did not develop infections.
HLA-DR expression on days 1, 3, 5, 7, 10 and 14 had a signif-
icant negative correlation with the SOFA score on these sub-
sequent days. After z-transformation, mean r = -0.416, 95%
confidence interval (CI; -0.56 to -0.25), p  < 0.01. The
correlation coefficient between HLA-DR expression and IL-6
was r = -0.055, 95% CI (-0.26 to 0.15), p = 0.60. The corre-
lation coefficient between HLA-DR expression and IL-10 was
r = -0.078, 95% CI (-0.28 to 0.13), p = 0.47.
Discussion
This study shows that, in the first days after RAAA repair,
patients develop a generalised increase in immunoregulatory
cytokines as reflected by elevated levels of IL-6 and IL-10.
HLA-DR expression on monocytes is reduced and remains
consistently low in non-survivors, while it returns to normal lev-
Table 1
Characteristics of the survivors and non-survivors
Survivors (N = 24) Non-survivors (N = 6) P
Demographic characteristics
Age 68 (64–72) 78 (73–79) <0.01
Sex (male) 21 (88%) 6 (100%) NS
Intra-operative data
Lowest systolic blood pressure (mmHg) 77 (53–90) 65 (23–79) NS
Blood-loss (litres) 3.8 (1.6–5.4) 4.8 (2.0–12.9) NS
Suprarenal clamping (yes) 5 (21%) 2 (33%) NS
Post-operative data
APACHE-II score 13 (9–16) 19 (16–23) 0.01
Re-operations (total) 10 4 NS
Sigmoid resection 2 (8%) 3 (50%) 0.04
Rebleeding 0 0 NS
Lower leg amputation 1 (4%) 0 NS
Infectious complications (total patients) 7 2 NS
Septic shock (17%) 2 (33%) NS
Abdominal infection 3 (13%) 1 (4%) NS
Pneumonia 4 (17%) 0 NS
CVC infection 2 (8%) 0 NS
Wound infection 0 1 (4%) NS
Renal replacement therapy 4 (17%)a 2 (33%)b NS
Hydrocortisone treatmentc 3 (13%) 1 (17%) NS
ICU length of stay (days) 7 (2–16) 8 (3–23) NS
Hospital length of stay (days) 20 (11–33) 8 (3–23) NS
Data are given as medians with interquartile range, or absolute number of patients with percentage of the total population. aAll patients had a full 
recovery of renal function at hospital discharge. bIn an additional two patients renal replacement therapy was indicated but not performed because 
it was considered futile. cHydrocortisone treatment was initiated for relative adrenal insufficiency. APACHE, Acute Physiology and Chronic Health 
Evaluation; CVC infection, central venous catheter related infection; ICU, intensive care unit; NS, non-significant.Critical Care    Vol 10 No 4    Haveman et al.
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els in survivors. Early high levels of IL-6 and IL-10 and subse-
quently reduced HLA-DR were all associated with multiple-
organ failure and death.
Several studies have shown that a severe inflammatory
response is associated with multiple organ failure and poor
outcome in RAAA patients [9,17,18]. It is believed that, in
RAAA patients, haemorrhagic shock, surgical trauma and
ischemia reperfusion injury all contribute to this overwhelming
inflammatory response. Blood-transfusions and surgery for
sigmoid necrosis may also modulate the inflammatory
response [19,20]. Our study confirms the presence of such an
inflammatory response by demonstrating an increased pro-
duction of IL-6. Furthermore, the SOFA score was significantly
higher in the non-survivors from day 1 through day 14, with an
increase in difference compared to survivors from day three
(Figure 1). The anti-inflammatory cytokine IL-10 was signifi-
cantly higher on days 1 and 3 in the non-survivors. Our find-
ings are in accordance with a study described by Lekkou and
colleagues [21] who studied 30 patients with severe sepsis
and noted that HLA-DR expression was lower in non-survivors.
Furthermore, these authors also found an initial high level of IL-
6 in non-survivors and high IL-10 on days 3, 10 and 13. The
association of an initial high level of IL-6 with organ failure and
poor outcome is confirmed in patients with sepsis, after
trauma and AAA patients [22-25]. The initial increase in IL-10
levels is also described in patients after orthopaedic trauma
and pancreatitis [26,27]. The initial hyperinflammatory state
followed by immunoparalysis, expressed as a prolonged
increase in IL-10, could not be confirmed in these patient
Table 2
Clinical data of the six non-survivors
Patient Age
(years)
Died on
day
Resuscitation
during surgery
Blood-loss
(l)
Complications Organ failure Infectious complication
1 79 2 - 7.0 Respiratory and renal -
2 80 3 - 9.5 Sigmoid necrosis, 
ischemic lower legs
Respiratory, cardiovascular 
and renal
-
3 74 4 - 2.0 Respiratory, cardiovascular 
and renal
-
4 79 12 - 2.5 Sigmoid necrosis Respiratory, hepatic, 
cardiovascular and renal
Enterococci in blood 
culture
5 79 21 - 3.0 Wound infection Respiratory, cardiovascular 
and renal
Proteus mirabilis in wound 
and blood
6 76 30 + 25.0 Sigmoid necrosis Respiratory, cardiovascular 
and renal
-
Figure 1
Sequential Organ Failure Assessment (SOFA) score after surgery for ruptured abdominal aortic aneurysm patients Sequential Organ Failure Assessment (SOFA) score after surgery for ruptured abdominal aortic aneurysm patients. The SOFA score was signifi-
cantly (as indicated by asterisks) higher in non-survivors than survivors from day one post-surgery onwards.Available online http://ccforum.com/content/10/4/R119
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groups. In patients with septic shock, Monneret and col-
leagues described a significantly lower HLA-DR expression
and higher IL-10 in non-survivors [28]. Caille and colleagues
[29] described that HLA-DR expression was low in septic
shock but not decreased in patients with haemorrhagic shock.
One might conclude that our data from RAAA patients are in
contrast with these findings. However, Caille and colleagues
described patients with trauma and postpartum haemorrhage;
these patients do not suffer from an additional ischemia
reperfusion injury. RAAA patients experience haemorrhagic
shock and ischemia reperfusion injury simultaneously.
The causal relationship between low HLA-DR expression and
poor outcome in ICU patients remains an interesting point of
discussion. In patients with sepsis, low HLA-DR expression is
associated with monocyte deactivation, an anti-inflammatory
cytokine profile, infectious complications and death [30,31]. In
patients with RAAA we could only partially confirm these find-
ings. As shown in Figure 4, a decrease in HLA-DR expression
on monocytes is associated with a poor outcome. However,
the presence of a sustained anti-inflammatory response in
these patients is difficult to envisage, considering the fact that
IL-10 levels are low from day three post-surgery, following an
initial rise. In our series, only two non-survivors developed cul-
ture-proven infection. One of these patients had necrosis of
the sigmoid colon and the other developed a wound infection
in the presence of extensive organ failure. The majority of the
patients died from multiple organ failure, not from overwhelm-
ing infection due to functional immunosuppression (Table 2).
In theory, early death from multiple organ failure may have pre-
vented the onset of severe infection, but this remains specula-
tive. Low HLA-DR expression in the non-survivors might also
be the result of their older age, although this correlation could
not be confirmed [32,33]. Alternatively, low HLA-DR expres-
sion may not be causally related to mortality. As such, HLA-DR
expression may be no more than a coincidental finding. Blood-
loss and sigmoid resection may also significantly alter the
immune response and HLA-DR expression, although no signif-
icant differences were found between these factors in survi-
vors versus non-survivors.
What can we do to improve the survival of RAAA and other
surgical patients? Since blood-loss and duration of surgery
are related to the development of multiple organ failure, metic-
ulous technique will increase the chances of survival. The
recent advances in endovascular surgery are promising [34-
Figure 2
IL-6 after ruptured abdominal aortic aneurysm repair IL-6 after ruptured abdominal aortic aneurysm repair. Levels of IL-6 
(normal value < 20 pg/ml) were significantly higher on day one in non-
survivors. *p < 0.05.
Figure 3
IL-10 after ruptured abdominal aortic aneurysm repair IL-10 after ruptured abdominal aortic aneurysm repair. Levels of IL-10 
(normal value < 10 pg/ml) were significantly higher on days one and 
three in non-survivors. *p < 0.05.
Figure 4
HLA-DR expression on monocytes after ruptured abdominal aortic  aneurysm repair HLA-DR expression on monocytes after ruptured abdominal aortic 
aneurysm repair. The expression of HLA-DR on monocytes (normal 
range 76% to 96%) of patients after RAAA is sharply and significantly 
decreased from day three post-surgery onwards. ap = 0.04; bp = 0.02; 
cp < 0.01.Critical Care    Vol 10 No 4    Haveman et al.
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36], although long-term durability is unknown [37-40].
Because of the shortcomings of endovascular surgery, RAAA
patients with a severe inflammatory response after open sur-
gery will continue to be presented to the ICU and a significant
number of them will not survive. In theory, hydrocortisone
might also lead to a better outcome in RAAA patients. In
patients with sepsis and relative adrenal insufficiency, hydro-
cortisone suppletion improves prognosis [41]. In addition Keh
and colleagues [42] showed that hydrocortisone restored
haemodynamic stability and modulated the immunological
response. These effects might also benefit RAAA patients
since adrenal insufficiency can be identified in a significant
amount of them [43]. The clinical effect of hydrocortisone sup-
pletion in RAAA patients needs to be evaluated further.
Our study has its limitations, mainly because of the small
patient numbers and the relatively low percentage of non-sur-
vivors. On the other hand, these low numbers were enough to
reach statistical significance on HLA-DR expression. This is
probably related to the fact that RAAA patients present as an
homogenous group with a well-defined insult, as reflected in
similar values for blood-loss, lowest systolic blood pressure
and suprarenal clamping.
Conclusion
Patients with RAAA displayed a severe inflammatory response
post-surgery, with markedly increased immunoregulatory
cytokines. HLA-DR expression was low in non-survivors from
the day of surgery onwards. In contrast to survivors, in whom
levels returned to normal values, it remained low. Organ failure
was present in non-survivors from day 1 and was the primary
cause of death. A relationship between impaired monocyte
function and death from infectious causes was not apparent in
our series. More likely, the severe initial insult in non-survivors
is probably responsible for both their low HLA-DR expression
on monocytes and their onset of fatal multiple organ failure.
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